Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Adv Exp Med Biol ; 662: 245-9, 2010.
Article in English | MEDLINE | ID: mdl-20204799

ABSTRACT

The relationship between changes in cerebral blood oxygenation and neuronal activity remains to be fully established. We compared somatosensory evoked potentials (SEP) and evoked cerebral blood oxygenation (CBO) changes in the sensorimotor cortex of the rat. In rats anesthetized with urethane and alpha-chloralose, we measured SEP and CBO using visible light spectroscopy (VLS) during neuronal activity. Increase of stimulus frequency caused a decrease of SEP amplitude, but an increase in concentration changes of deoxy-Hb and oxygen saturation. The difference in frequency responses between SEP and CBO might be caused by activation of inhibitory neurons, which could suppress excitatory neurons at high stimulus frequencies; activation of inhibitory neurons could reduce SEP amplitude, and increase oxygen saturation due to an increase of evoked cerebral blood flow.


Subject(s)
Cerebral Cortex/physiology , Evoked Potentials, Somatosensory/physiology , Oxygen/blood , Animals , Hemoglobins/metabolism , Rats , Rats, Inbred F344 , Spectrum Analysis
2.
J Neurotrauma ; 26(11): 1935-41, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19469687

ABSTRACT

Accumulating data suggest that matrix metalloproteinases (MMPs) may be important mediators in the pathophysiology of acute brain injury after trauma or stroke. Here, we test the hypothesis that the endogenous tissue inhibitor of metalloproteinase (TIMP-1) is neuroprotective in vitro and in vivo. For in vitro studies, primary cortical neuronal cultures were subjected to hypoxia and reoxygenation. Treatment with recombinant TIMP-1 protein significantly decreased neuronal death. In vivo studies in models of brain trauma and stroke supported these cell culture results. After controlled cortical impact, 24-h MMP-9 levels were significantly reduced in transgenic mice overexpressing TIMP-1 compared to wild-type mice. And at 7 days post-trauma, brain lesion volumes were also significantly decreased by TIMP-1 overexpression as well. In a model of transient 2-h focal cerebral ischemia, MMP-9 levels were lower in TIMP-1 transgenic mice compared with wild-types. Correspondingly, blood-brain barrier leakage was ameliorated by TIMP-1 overexpression, and 24-h infarction volumes were also reduced. Taken together, these cell culture and in vivo data provide initial proof-of-principle that TIMP-1 is neuroprotective against traumatic and ischemic brain injury in mice.


Subject(s)
Brain Injuries/metabolism , Hypoxia-Ischemia, Brain/metabolism , Neurons/metabolism , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Animals , Brain Injuries/pathology , Cell Death , Cells, Cultured , Disease Models, Animal , Hypoxia-Ischemia, Brain/pathology , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Transgenic , Neurons/pathology , Tissue Inhibitor of Metalloproteinase-1/genetics
3.
Stroke ; 39(6): 1869-74, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18403737

ABSTRACT

BACKGROUND AND PURPOSE: Emerging data suggest that neuroglobin (Ngb) may protect against hypoxic/ischemic neuronal insults. However, the underlying mechanisms in vivo and implications for long-term outcomes are still not well understood. METHODS: Using our newly created Ngb overexpressing transgenic (Ngb-Tg) mice, we measured brain infarction on day 1 and day 14 after transient focal cerebral ischemia and performed neurobehavioral assessments in sensorimotor deficits on days 1, 3, 7, and 14. To test the hypothesis that Ngb may play a role in reducing oxidative stress after stroke, intracellular malondialdehyde levels were measured and compared in Ngb-Tg and wild-type mice. RESULTS: Increased Ngb mRNA and protein levels were identified in Ngb-Tg brains. Malondialdehyde levels in ischemic hemispheres of Ngb-Tg were significantly reduced compared with wild-type controls at 8 hours and 22 hours after transient focal cerebral ischemia. Compared with wild-type controls, brain infarction volumes 1 day and 14 days after transient focal cerebral ischemia were significantly reduced in Ngb-Tg mice. However, there were no significant improvements in sensorimotor deficits for up to 14 days after stroke in Ngb-Tg mice compared with wild-type controls. CONCLUSIONS: Ngb reduces tissue infarction and markers of oxidative stress after stroke. Tissue protection by overexpressing Ngb can be sustained for up to 2 weeks.


Subject(s)
Brain Ischemia/metabolism , Cerebral Infarction/metabolism , Globins/metabolism , Nerve Tissue Proteins/metabolism , Oxidative Stress/genetics , Acute Disease/therapy , Animals , Biomarkers/metabolism , Brain Ischemia/genetics , Brain Ischemia/physiopathology , Cerebral Infarction/genetics , Cerebral Infarction/physiopathology , Cytoprotection/genetics , Disease Models, Animal , Gene Expression Regulation/genetics , Genetic Therapy/methods , Globins/genetics , Malondialdehyde/metabolism , Mice , Mice, Transgenic , Nerve Tissue Proteins/genetics , Neuroglobin , RNA, Messenger/metabolism , Time , Time Factors , Up-Regulation/genetics
4.
Stroke ; 39(2): 439-47, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18187690

ABSTRACT

BACKGROUND AND PURPOSE: The use of lithium as a neuroprotective agent has been demonstrated using various models in which improvements in infarct size, DNA damage, and neurological function were reported. We further investigated neurohemodynamic aspects of the treatment-associated recovery by assessing the therapeutic efficacy of delayed chronic lithium treatment using functional MRI. METHODS: Ipsilesional functional MRI activations in the somatosensory cortex, acquired 2 weeks after the 90-minute transient middle cerebral artery occlusion, were compared between lithium- and saline-treated rats. Specifically, MRI signal changes based on blood oxygenation level dependence and functional cerebral blood volume responses were examined using electrical stimulation of forelimbs. Additional immunohistochemical assays were performed. RESULTS: The ratio of ipsilesional to contralesional blood oxygenation level dependence response magnitudes significantly improved with lithium treatments. In contrast, the increase of the functional cerebral blood volume response magnitude ratio was not statistically significant. Nonetheless, the lithium treatment induced significant enhancements of total functional MRI activation (defined as a product of activation volume and response magnitude) for both blood oxygenation level dependence and functional cerebral blood volume methods. Increased cerebral blood volume in periinfarct tissues suggests a possible stroke-induced vascular transformation in both saline- and lithium-treated rats; however, other MRI-derived vascular parameters (vascular size index and microvascular volume) and immunohistochemical staining (CD31, glia fibrillary-associated protein, and matrix metalloproteinase-9) may imply that the neoformation of vasculature was differently affected by the lithium treatment. CONCLUSIONS: The delayed chronic lithium treatment enhanced the blood oxygenation level dependence functional MRI response magnitude in the absence of neurological improvement and influenced vascular formation in poststroke animal models.


Subject(s)
Brain Ischemia/drug therapy , Infarction, Middle Cerebral Artery/drug therapy , Lithium Chloride/pharmacology , Magnetic Resonance Imaging , Neuroprotective Agents/pharmacology , Animals , Cerebrovascular Circulation/drug effects , Disease Models, Animal , Male , Models, Neurological , Oxygen/blood , Rats , Rats, Sprague-Dawley
5.
Stroke ; 38(2 Suppl): 748-52, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17261731

ABSTRACT

Matrix metalloproteinases (MMPs) mediate tissue injury during acute stroke. Clinical data show that elevated MMPs in plasma of stroke patients may correlate with outcomes, suggesting its use as a biomarker. MMP-9 signal has also been detected in clinical stroke brain tissue samples. Because tissue plasminogen activator can upregulate MMPs via lipoprotein receptor signaling, these neurovascular proteolytic events may underlie some of the complications of edema and hemorrhage that plague thrombolytic therapy. However, in contrast to its deleterious actions in acute stroke, MMPs and other neurovascular proteases may play beneficial roles during stroke recovery. MMPs are increased in the subventricular zone weeks after focal stroke, and inhibition of MMPs suppress neurogenic migration from subventricular zone into damaged tissue. In peri-infarct cortex, MMPs may mediate neurovascular remodeling. Delayed inhibition of MMPs decrease markers of remodeling, and these phenomena may be related to reductions in bioavailable growth factors. Acute versus chronic protease profiles within the neurovascular unit are likely to underlie critical responses to stroke, therapy, and recovery.


Subject(s)
Brain Injuries/enzymology , Cerebral Hemorrhage/enzymology , Cerebrovascular Circulation/drug effects , Peptide Hydrolases/metabolism , Stroke/enzymology , Brain Injuries/complications , Brain Injuries/drug therapy , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/drug therapy , Humans , Stroke/complications , Stroke/drug therapy
6.
J Cereb Blood Flow Metab ; 27(1): 142-53, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16736052

ABSTRACT

Accumulating experimental and clinical data suggest that albumin may be neuroprotective for stroke. Here, we use functional magnetic resonance imaging (fMRI) to evaluate the therapeutic efficacy of albumin and its effects on the recovery of stimuli-induced cerebral hemodynamics. For this purpose, fMRI activity in the ipsilesional somatosensory (SS) cortex was assessed using a well established rat model of transient 90 min focal ischemia and electrical forelimb stimulation. Rats were treated with either saline or albumin via intracerebroventricular injections at 12 h post-stroke onset. Despite this delayed treatment time, when compared to the saline-treated rats (n=7), there were significant enhancements of the fMRI activation in the albumin-treated rats (n=6) for both blood oxygenation level dependence (BOLD) and functional cerebral blood volume (fCBV) responses. Interestingly, the temporal characteristics of the ipsilesional SS BOLD responses in the albumin-treated rats appeared considerably altered compared to those of contralesional responses while such temporal alterations were not pronounced for the fCBV responses. These characteristic fMRI temporal profiles of the albumin-treated brains may be due to altered neuronal responses rather than altered integrity of neurovascular coupling, which implies an unusually fast habituation of neuronal responses in the lesional SS cortex. The correlation between various MRI-derived structural parameters and the fMRI response magnitude was also characteristic for albumin and control groups. Taken together, these data suggest that restoration of fMRI response magnitudes, temporal profiles, and correlations with structure may reveal the extent and specific traits of albumin treatment associated stroke recovery.


Subject(s)
Albumins/therapeutic use , Neurons/physiology , Stroke/drug therapy , Stroke/pathology , Algorithms , Animals , Blood Volume/drug effects , Blood Volume/physiology , Cerebrovascular Circulation/drug effects , Cerebrovascular Circulation/physiology , Computer Simulation , Data Interpretation, Statistical , Image Processing, Computer-Assisted , Infarction, Middle Cerebral Artery/pathology , Injections, Intraventricular , Magnetic Resonance Imaging , Male , Motor Cortex/pathology , Neurons/drug effects , Neurons/pathology , Oxygen/blood , Rats , Rats, Sprague-Dawley , Somatosensory Cortex/pathology
7.
J Cereb Blood Flow Metab ; 27(3): 460-8, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16788715

ABSTRACT

We tested the hypothesis that astrocytic matrix metalloproteinase-9 (MMP-9) mediates hemorrhagic brain edema. In a clinical case of hemorrhagic stroke, MMP-9 co-localized with astrocytes and neurons in peri-hematoma areas. In a mouse model where blood was injected into striatum, MMP-9 was colocalized with astrocytes surrounding the hemorrhagic lesion. Because MMP-9 is present in blood as well as brain, we compared four groups of wild type (WT) and MMP-9 knockout (KO) mice: WT blood injected into WT brain, KO blood into KO brain, WT blood into KO brain, and KO blood into WT brain. Gel zymography showed that MMP-9 was elevated in WT hemorrhagic brain tissue but absent from KO hemorrhagic brain tissue. Edematous water content was elevated when WT blood was injected into WT brain. However, edema was ameliorated when MMP-9 was absent in either blood or brain or both. To further assess the mechanisms involved in astrocytic induction of MMP-9, we next examined primary mouse astrocyte cultures. Exposure to hemoglobin rapidly upregulated MMP-9 in conditioned media within 1 to 24 h. Hemoglobin-induced MMP-9 was reduced by the free radical scavenger U83836E. Taken together, these data suggest that although there are large amounts of MMP-9 in blood, hemoglobin-induced oxidative stress can trigger MMP-9 in astrocytes and these parenchymal sources of matrix degradation may also be an important factor in the pathogenesis of hemorrhagic brain edema.


Subject(s)
Astrocytes/enzymology , Brain Edema/physiopathology , Cerebral Hemorrhage/physiopathology , Matrix Metalloproteinase 9/metabolism , Animals , Brain Edema/etiology , Brain Edema/metabolism , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/metabolism , Hemoglobins/metabolism , Humans , Immunohistochemistry , Male , Mice , Mice, Knockout , Neurons/enzymology , Oxidative Stress/physiology , Stroke/complications , Stroke/metabolism , Stroke/pathology
8.
Thromb Haemost ; 94(4): 791-6, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16270632

ABSTRACT

Neurotoxic effects of endogenous tissue plasminogen activator (tPA) have recently been reported. Employing a rat model of thromboembolic stroke, we evaluated the extent and degree of extravasation of exogenous tPA administered for the purpose of fibrinolysis. In a thromboembolic model using Sprague-Dawley rats, focal cerebral ischemia was induced at the territory of the middle cerebral artery (MCA). Early reperfusion was induced by administering tPA (10 mg/kg) intravenously at 30 minutes after the onset of ischemia. Extravasated tPA was evaluated by immunohistochemistry, and the concentration of tPA in the brain tissue was quantified by enzyme-linked immunosorbent assay methods. The integrity of the blood-brain barrier (BBB) was examined electronmicroscopically. In a thread model of transient ischemia, reperfusion was induced without tPA administration at 30 minutes or 2 hours after the onset of ischemia, and the tPA content of the brain was quantified. In the rats with thromboembolic stroke, extravasation of tPA was observed at the territory of the MCA. Both the endogenous and exogenous tPA contents were 3.5 +/- 1.6 ng/ml of homogenized brain in saline. Electronmicroscopically, mild ischemic changes were observed, although the integrity of the BBB was preserved. In the thread model rats, the endogenous tPA contents of the ischemic hemisphere were 0.9 +/- 0.1 and 1.0 +/- 0.2 ng/ml in the 30-minute and 2-hour ischemia groups, respectively, and were significantly lower than the tPA contents in the thromboembolic stroke rats (p<0.01). The present findings indicate that significant extravasation of exogenous tPA occurs through the cerebral vessels even though early reperfusion is induced.


Subject(s)
Fibrinolytic Agents/pharmacokinetics , Infarction, Middle Cerebral Artery/drug therapy , Infarction, Middle Cerebral Artery/metabolism , Tissue Plasminogen Activator/pharmacokinetics , Animals , Blood-Brain Barrier , Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Cerebrovascular Circulation , Disease Models, Animal , Extravasation of Diagnostic and Therapeutic Materials , Fibrinolytic Agents/toxicity , Male , Rats , Rats, Sprague-Dawley , Somatosensory Cortex/blood supply , Somatosensory Cortex/metabolism , Tissue Plasminogen Activator/toxicity
9.
Stroke ; 36(9): 1954-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16051896

ABSTRACT

BACKGROUND AND PURPOSE: Thrombolytic therapy with tissue plasminogen activator (tPA) in ischemic stroke is limited by increased risks of cerebral hemorrhage and brain injury. In part, these phenomena may be related to neurovascular proteolysis mediated by matrix metalloproteinases (MMPs). Here, we used a combination of pharmacological and genetic approaches to show that tPA promotes MMP-9 levels in stroke in vivo. METHODS: In the first experiment, spontaneously hypertensive rats were subjected to 3 hours of transient focal cerebral ischemia. The effects of tPA (10 mg/kg IV) on ischemic brain MMP-9 levels were assessed by zymography. In the second experiment, wild-type (WT) and tPA knockout mice were subjected to 2 hours of transient focal cerebral ischemia, and MMP-9 levels and brain edema during reperfusion were assessed. Phenotype rescue was performed by administering tPA to the tPA knockout mice. RESULTS: In the first experiment, exogenous tPA did not change infarct size but amplified MMP-9 levels in ischemic rat brain at 24 hours. Coinfusion of the plasmin inhibitor tranexamic acid (300 mg/kg) did not ameliorate this effect, suggesting that it was independent of plasmin. In the second experiment, ischemic MMP-9 levels, infarct size, and brain edema in tPA knockouts were significantly lower than WT mice. Administration of exogenous tPA (10 mg/kg IV) did not alter infarction but reinstated the ischemic MMP-9 response back up to WT levels and correspondingly worsened edema. CONCLUSIONS: These data demonstrate that tPA upregulates brain MMP-9 levels in stroke in vivo, and suggest that combination therapies targeting MMPs may improve tPA therapy.


Subject(s)
Brain Ischemia/metabolism , Brain Ischemia/therapy , Matrix Metalloproteinase 9/biosynthesis , Tissue Plasminogen Activator/metabolism , Up-Regulation , Animals , Blood-Brain Barrier , Brain/pathology , Brain Infarction/pathology , Disease Models, Animal , Edema/metabolism , Edema/pathology , Electrophoresis, Polyacrylamide Gel , Fibrinolysin/metabolism , Humans , Hydrogen/metabolism , Immunohistochemistry , Ischemia/pathology , Matrix Metalloproteinase 2/biosynthesis , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Perfusion , Phenotype , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Time Factors
10.
J Cereb Blood Flow Metab ; 25(7): 820-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15758949

ABSTRACT

Brain responses to external stimuli after permanent and transient ischemic insults have been documented using cerebral blood volume weighted (CBVw) functional magnetic resonance imaging (fMRI) in correlation with tissue damage and neurological recovery. Here, we extend our previous studies of stroke recovery in rat models of focal cerebral ischemia by comparing blood oxygen level-dependent (BOLD) and cerebral blood volume (CBV) changes. Responses to forepaw stimulation were measured in normal rats (n=5) and stroke rats subjected to 2 h of middle cerebral artery occlusion (n=6). Functional magnetic resonance imaging was performed 2 weeks after stroke to evaluate the recovery process. After stroke, animals showed variable degrees of fMRI activation in ipsilesional cortex, the extent of which did not correlate with structural damages as measured using apparent diffusion coefficient, fractional anisotropy, blood volume, and vessel size index. While the contralesional cortex showed good overlap between BOLD and CBV-activated regions, the ipsilesional cortex showed low covariance between significantly activated voxels by BOLD and CBVw techniques. In particular, the relative activation during contralateral stimuli in the ipsilesional somatosensory cortex was significantly higher for CBVw responses than BOLD, which might be due to stroke-related alterations in fMRI hemodynamic coupling. Aberrant subcortical activations were also observed. When unaffected forelimbs were stimulated, strong bilateral responses were observed. However, little thalamic responses accompanied stimulation of affected forelimbs despite significant activation in the ipsilesional somatosensory cortex. These results suggest that stroke affects not only local hemodynamics and coupling but also other factors including neural connectivity.


Subject(s)
Brain Ischemia/diagnosis , Brain Ischemia/physiopathology , Hemodynamics/physiology , Animals , Blood Volume/physiology , Brain Ischemia/blood , Magnetic Resonance Imaging , Oxygen/blood , Rats , Rats, Sprague-Dawley
11.
Neurol Res ; 25(5): 477-80, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12866195

ABSTRACT

Using a rat model of thromboembolic stroke we evaluated whether or not fibrinolysis by bolus injection of pamiteplase, a modified tissue plasminogen activator (tPA) with a longer half-life, reduces infarction volume. Infarction volume was significantly reduced by the early administration of pamiteplase at 2 h after the onset of ischemia. Hemorrhagic infarction was observed only in 3 of 10 rats (30%) treated at 6 h. Thus, bolus injection of pamiteplase can reduce infarction volume suppressing the incidence of hemorrhage.


Subject(s)
Cerebral Infarction/drug therapy , Cerebral Infarction/therapy , Recombinant Proteins/pharmacology , Thrombolytic Therapy , Tissue Plasminogen Activator/pharmacology , Acute Disease , Animals , Cerebral Hemorrhage/prevention & control , Disease Models, Animal , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...